Shunichi Kitajima
Director/Board Member bei TRANS GENIC INC.
Vermögen: 36 735 $ am 31.03.2024
Profil
Shunichi Kitajima is currently the Director & GM-Contract Research Organization at Trans Genic Inc., the Director at New Drug Research Center Inc., and the Director at Biosafety Research Center, Inc. He previously worked as the Director at GeneticLab Co., Ltd.
from 2017 to 2022.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
TRANS GENIC INC.
0,14% | 31.03.2023 | 23 069 ( 0,14% ) | 36 735 $ | 31.03.2024 |
Aktive Positionen von Shunichi Kitajima
Unternehmen | Position | Beginn |
---|---|---|
TRANS GENIC INC. | Director/Board Member | 01.06.2015 |
New Drug Research Center Inc.
New Drug Research Center Inc. Miscellaneous Commercial ServicesCommercial Services New Drug Research Center Inc. engages in the research, development and support of medical products, medical equipment, and chemical substances. It performs drugs and food clinical trials and tests compatible with good clinical practice (GCP). The company was founded in April 2013 and is headquartered in Tokyo, Japan. | Director/Board Member | 01.04.2013 |
Biosafety Research Center, Inc.
Biosafety Research Center, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Trans Genic Inc., Biosafety Research Center, Inc. is a safety test contractor that supports pharmaceuticals and food development. The private company is based in Iwata, Japan. The Japanese company is entrusted with clinical tests in animal species that are commonly used and analysis of subject substances and biological components in biological samples. The company offers physical properties analysis, spectrum measurement of the sample, water, ash, and content analysis. The company has developed several mouse models for stress visualization and gene visualization of oxidative stress. The company also conducts reproductive toxicity tests to examine the effects of subject substances on the reproductive function of the parent generation and the occurrence of the next generation. | Director/Board Member | 01.03.2018 |
Ehemalige bekannte Positionen von Shunichi Kitajima
Unternehmen | Position | Ende |
---|---|---|
GeneticLab Co., Ltd.
GeneticLab Co., Ltd. Miscellaneous Commercial ServicesCommercial Services GeneticLab Co., Ltd. provides gene expression analysis and pathological diagnostic services. It also engages in medical care development services. The company was founded on September 1, 2000 and is headquartered in Sapporo, Japan. | Director/Board Member | 01.01.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TRANS GENIC INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
New Drug Research Center Inc.
New Drug Research Center Inc. Miscellaneous Commercial ServicesCommercial Services New Drug Research Center Inc. engages in the research, development and support of medical products, medical equipment, and chemical substances. It performs drugs and food clinical trials and tests compatible with good clinical practice (GCP). The company was founded in April 2013 and is headquartered in Tokyo, Japan. | Commercial Services |
GeneticLab Co., Ltd.
GeneticLab Co., Ltd. Miscellaneous Commercial ServicesCommercial Services GeneticLab Co., Ltd. provides gene expression analysis and pathological diagnostic services. It also engages in medical care development services. The company was founded on September 1, 2000 and is headquartered in Sapporo, Japan. | Commercial Services |
Biosafety Research Center, Inc.
Biosafety Research Center, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Trans Genic Inc., Biosafety Research Center, Inc. is a safety test contractor that supports pharmaceuticals and food development. The private company is based in Iwata, Japan. The Japanese company is entrusted with clinical tests in animal species that are commonly used and analysis of subject substances and biological components in biological samples. The company offers physical properties analysis, spectrum measurement of the sample, water, ash, and content analysis. The company has developed several mouse models for stress visualization and gene visualization of oxidative stress. The company also conducts reproductive toxicity tests to examine the effects of subject substances on the reproductive function of the parent generation and the occurrence of the next generation. | Commercial Services |